← brief for 2026-10-04 · Transplant & xeno
Metformin and Empagliflozin Attenuate Visceral Adiposity After Kidney Transplantation: Supporting Data
Key takeaways
This is a data set from a study that looked at how two diabetes drugs affect body fat after a kidney transplant. It contains the raw numbers from the trial, but it is not the main study itself. There are no new results in this item, just the supporting data.
Who did this work
Yangming Tang · Turun Song
Source
Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-10-03
https://doi.org/10.6084/m9.figshare.33077843